Regenerative Medical Technology (RMTG) EPS (Basic) (2018 - 2026)
Regenerative Medical Technology (RMTG) posted quarterly EPS (Basic) of -$0.15 for Q1 2026, down 145.93% year-over-year from $0.32 in Q1 2025, and up 18.52% quarter-over-quarter from -$0.18 in Q4 2025.
Regenerative Medical Technology (RMTG) EPS (Basic) (2018 - 2026) Analysis & Trends
Regenerative Medical Technology's EPS (Basic) history runs 9 years deep, the most recent figure standing at -$0.15 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 145.93% year-over-year to -$0.15; the TTM figure through Mar 2026 stood at -$0.72 (down 108.22% YoY), while the FY2025 annual figure was -$0.68, down 43.62% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.15, up from -$0.18 in the prior quarter.
- The five-year high for EPS (Basic) was $0.38 in Q4 2023, with the low at -$0.31 in Q3 2025.
- The 5-year median for EPS (Basic) is -$0.06 (2025), against an average of -$0.06.
- Peak annual rise in EPS (Basic) reached 6652.54% in 2023, while the deepest fall reached 452656.74% in 2023.
- Regenerative Medical Technology's EPS (Basic) stood at $0.01 in 2022, then jumped by 6652.54% to $0.38 in 2023, then sank by 113.44% to -$0.05 in 2024, then slumped by 259.12% to -$0.18 in 2025, then advanced by 18.52% to -$0.15 in 2026.
- Business Quant data shows RMTG's EPS (Basic) at -$0.15 in Q1 2026, -$0.18 in Q4 2025, and -$0.31 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 0.18 |
| 10 | Regenerative Medical Technology | 814,616.00 | -246,832.00 | 1.77 Mn | -0.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.15 |
| Dec 31, 2025 | -0.18 |
| Sep 30, 2025 | -0.31 |
| Jun 30, 2025 | -0.10 |
| Mar 31, 2025 | -0.06 |
| Dec 31, 2024 | -0.05 |
| Sep 30, 2024 | -0.07 |
| Jun 30, 2024 | -0.17 |
| Mar 31, 2024 | -0.16 |
| Dec 31, 2023 | 0.38 |
| Sep 30, 2023 | -0.14 |
| Jun 30, 2023 | -0.03 |
| Mar 31, 2023 | -0.05 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.10 |
| Sep 30, 2021 | -0.82 |
| Jun 30, 2021 | -0.06 |